Lysentech
Seongnam-si, KR· latest recorded location
LYSENTECH is named on 3 US grants and 3 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 3
- Published applications
- 3
- Inventors
- 8
- Granted in 2026 so far
- 0
- Most recent grant
- 1 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 2 | 0 |
By publication year.
Technology areas
Share of 6 documents
- C12NMicroorganisms or enzymes6
- A61KMedicines and medical preparations5
- A61PTherapeutic uses of medicines5
- C07KPeptides5
- C12YEnzymes4
- Y02ATechnologies for adaptation to climate change4
- A01NPreservation of bodies of humans or animals or plants or parts thereof2
- A01PBiocidal, pest repellant, pest attractant or plant growth regulatory activity of chemical2
- A23KFodder2
- C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms2
Recent patents
- Polypeptides and antibiotics against gram-negative bacterium comprising the same1 Oct 2024US 12,102,667 B2
- Composition and method for increasing production of bacteriophage using reactive oxygen species13 Feb 2024US 11,898,171 B2
- Polypeptide, fusion polypeptide, and antibiotic against gram-negative bacteria comprising same7 Nov 2023US 11,807,881 B2
- Novel polypeptides and antibiotics against Gram-negative bacterium comprising the same8 Dec 2022US 2022/0387563 A1
- Polypeptide, fusion polypeptide, and antibiotic against gram-negative bacteria comprising same3 Nov 2022US 2022/0348895 A1
- Oncolytic t7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating cancer14 Jan 2021US 2021/0009963 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.